SCHEMBL25098583

SCHEMBL25098583

CCCCC(CC)CCCCNC(=O)CC

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.61
▸ KMT2A Q03164 1/20 0.61
▸ CA2 P00918 2/20 0.49
▸ CASP2 P42575 1/20 0.47
▸ DPP7 Q9UHL4 1/20 0.46
▸ MMP9 P14780 1/20 0.46
▸ MMP8 P22894 1/20 0.46
▸ MMP14 P50281 1/20 0.46
▸ NAAA Q02083 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ EPHX1 P07099 4/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ FAAH O00519 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ GNAI3 P08754 1/20 0.41
▸ GNAO1 P09471 1/20 0.41
▸ GNAI1 P63096 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23375897 0.82 CA2 (0.58) CA2CASP2DPP7MMP9MMP8
SCHEMBL8515067 0.81 TSHR (0.55) MEN1KMT2ACA2ALDH1A1CYP3A4
SCHEMBL18723105 0.81 EPHX1 (0.65) CA2DPP7MMP9MMP8MMP14
SCHEMBL30799757 0.81 CASP2 (0.55) MEN1KMT2ACASP2DPP7MMP9
SCHEMBL718284 0.80 MEN1 (0.85) MEN1KMT2ACASP2NAAAEPHX1
SCHEMBL3708747 0.78 MEN1 (0.81) MEN1KMT2ACASP2NAAAEPHX1
SCHEMBL2944555 0.78 MEN1 (0.81) MEN1KMT2ACASP2NAAAEPHX1
SCHEMBL1901704 0.78 MEN1 (0.81) MEN1KMT2ACASP2NAAAEPHX1
SCHEMBL5436704 0.78 MEN1 (0.81) MEN1KMT2ACASP2NAAAEPHX1
SCHEMBL10866272 0.78 MEN1 (0.81) MEN1KMT2ACASP2NAAAEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230076803-A1 COMPOUND AND DRUG CONJUGATE, AND PREPARATION METHOD AND USE THEREOF Suzhou Ribo Life Science Co., Ltd. (CN) 2023-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230076803-A1 COMPOUND AND DRUG CONJUGATE, AND PREPARATION METHOD AND USE THEREOF ABCG2, ABCB1, SLC10A1 MEN1 762/4885KMT2A 2507/4885CA2 3840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback